503 related articles for article (PubMed ID: 25891236)
1. Subsets of myeloid-derived suppressor cells in hepatocellular carcinoma express chemokines and chemokine receptors differentially.
Zhao W; Xu Y; Xu J; Wu D; Zhao B; Yin Z; Wang X
Int Immunopharmacol; 2015 Jun; 26(2):314-21. PubMed ID: 25891236
[TBL] [Abstract][Full Text] [Related]
2. Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth.
Schlecker E; Stojanovic A; Eisen C; Quack C; Falk CS; Umansky V; Cerwenka A
J Immunol; 2012 Dec; 189(12):5602-11. PubMed ID: 23152559
[TBL] [Abstract][Full Text] [Related]
3. The spleen contributes to the increase in PMN-MDSCs in orthotopic H22 hepatoma mice.
Li BH; Jiang W; Zhang S; Huang N; Sun J; Yang J; Li ZF
Mol Immunol; 2020 Sep; 125():95-103. PubMed ID: 32659598
[TBL] [Abstract][Full Text] [Related]
4. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.
Schouppe E; Mommer C; Movahedi K; Laoui D; Morias Y; Gysemans C; Luyckx A; De Baetselier P; Van Ginderachter JA
Eur J Immunol; 2013 Nov; 43(11):2930-42. PubMed ID: 23878002
[TBL] [Abstract][Full Text] [Related]
5. Myeloid-derived suppressor cell functionality and interaction with Leishmania major parasites differ in C57BL/6 and BALB/c mice.
Schmid M; Zimara N; Wege AK; Ritter U
Eur J Immunol; 2014 Nov; 44(11):3295-306. PubMed ID: 25142017
[TBL] [Abstract][Full Text] [Related]
6. Functional characterization of myeloid-derived suppressor cell subpopulations during the development of experimental arthritis.
Wang W; Jiao Z; Duan T; Liu M; Zhu B; Zhang Y; Xu Q; Wang R; Xiong Y; Xu H; Lu L
Eur J Immunol; 2015 Feb; 45(2):464-73. PubMed ID: 25352399
[TBL] [Abstract][Full Text] [Related]
7. CCL9/CCR1 induces myeloid‑derived suppressor cell recruitment to the spleen in a murine H22 orthotopic hepatoma model.
Li B; Zhang S; Huang N; Chen H; Wang P; Yang J; Li Z
Oncol Rep; 2019 Jan; 41(1):608-618. PubMed ID: 30365155
[TBL] [Abstract][Full Text] [Related]
8. CCR5 Directs the Mobilization of CD11b
Hawila E; Razon H; Wildbaum G; Blattner C; Sapir Y; Shaked Y; Umansky V; Karin N
Cell Rep; 2017 Nov; 21(8):2212-2222. PubMed ID: 29166611
[TBL] [Abstract][Full Text] [Related]
9. Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCs.
Tannenbaum CS; Rayman PA; Pavicic PG; Kim JS; Wei W; Polefko A; Wallace W; Rini BI; Morris-Stiff G; Allende DS; Hamilton T; Finke JH; Diaz-Montero CM
Cancer Immunol Res; 2019 Oct; 7(10):1687-1699. PubMed ID: 31439615
[TBL] [Abstract][Full Text] [Related]
10. Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy.
Sun L; Clavijo PE; Robbins Y; Patel P; Friedman J; Greene S; Das R; Silvin C; Van Waes C; Horn LA; Schlom J; Palena C; Maeda D; Zebala J; Allen CT
JCI Insight; 2019 Apr; 4(7):. PubMed ID: 30944253
[TBL] [Abstract][Full Text] [Related]
11. The Voltage-Gated Hv1 H
Cozzolino M; Gyöngyösi A; Korpos E; Gogolak P; Naseem MU; Kállai J; Lanyi A; Panyi G
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047188
[TBL] [Abstract][Full Text] [Related]
12. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function.
Nam S; Kang K; Cha JS; Kim JW; Lee HG; Kim Y; Yang Y; Lee MS; Lim JS
J Leukoc Biol; 2016 Dec; 100(6):1273-1284. PubMed ID: 27601624
[TBL] [Abstract][Full Text] [Related]
13. [Expression and significance of myeloid-derived suppressor cells-associated chemokine MIP-1γ and its receptor CCR1 in the spleen of hepatoma H22-bearing mice].
Li B; Chen H; Shi M; Huang N; Kong G; Li Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Sep; 36(9):802-808. PubMed ID: 32967764
[TBL] [Abstract][Full Text] [Related]
14. Functional changes in myeloid-derived suppressor cells (MDSCs) during tumor growth: FKBP51 contributes to the regulation of the immunosuppressive function of MDSCs.
Kim YS; Kim YJ; Lee JM; Kim EK; Park YJ; Choe SK; Ko HJ; Kang CY
J Immunol; 2012 May; 188(9):4226-34. PubMed ID: 22474024
[TBL] [Abstract][Full Text] [Related]
15. Myeloid-derived suppressor cells are essential partners for immune checkpoint inhibitors in the treatment of cisplatin-resistant bladder cancer.
Takeyama Y; Kato M; Tamada S; Azuma Y; Shimizu Y; Iguchi T; Yamasaki T; Gi M; Wanibuchi H; Nakatani T
Cancer Lett; 2020 Jun; 479():89-99. PubMed ID: 32200039
[TBL] [Abstract][Full Text] [Related]
16. The Development and Homing of Myeloid-Derived Suppressor Cells: From a Two-Stage Model to a Multistep Narrative.
Karin N
Front Immunol; 2020; 11():557586. PubMed ID: 33193327
[TBL] [Abstract][Full Text] [Related]
17. Myeloid-derived suppressor cell function is diminished in aspirin-triggered allergic airway hyperresponsiveness in mice.
Shi M; Shi G; Tang J; Kong D; Bao Y; Xiao B; Zuo C; Wang T; Wang Q; Shen Y; Wang H; Funk CD; Zhou J; Yu Y
J Allergy Clin Immunol; 2014 Nov; 134(5):1163-74.e16. PubMed ID: 24948368
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory microenvironment and expression of chemokines in hepatocellular carcinoma.
Han KQ; He XQ; Ma MY; Guo XD; Zhang XM; Chen J; Han H; Zhang WW; Zhu QG; Nian H; Ma LJ
World J Gastroenterol; 2015 Apr; 21(16):4864-74. PubMed ID: 25944999
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia induces myeloid-derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C-C motif) ligand 26.
Chiu DK; Xu IM; Lai RK; Tse AP; Wei LL; Koh HY; Li LL; Lee D; Lo RC; Wong CM; Ng IO; Wong CC
Hepatology; 2016 Sep; 64(3):797-813. PubMed ID: 27228567
[TBL] [Abstract][Full Text] [Related]
20. Glioma-derived CCL2 and CCL7 mediate migration of immune suppressive CCR2
Takacs GP; Kreiger CJ; Luo D; Tian G; Garcia JS; Deleyrolle LP; Mitchell DA; Harrison JK
Front Immunol; 2022; 13():993444. PubMed ID: 36685592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
